Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT02499731
Other study ID # IRB #: 1402004505
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date March 2014
Est. completion date February 15, 2020

Study information

Verified date April 2020
Source Cornell University
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Strong Hearts, Healthy Communities is a research study which aims to reduce cardiovascular disease (CVD), improve quality of life, and reduce CVD related health care costs in rural communities.

The investigators' aim is to better understand how changes in lifestyle can affect the health of rural women and others in their communities.


Description:

There are notable cardiovascular disease (CVD) disparities among people living in rural settings, particularly medically underserved rural areas. Complex factors such as socioeconomic disadvantage, social and cultural dynamics, geographic distances/barriers, and limited access to healthcare, healthy foods, and/or physical activity opportunities contribute to the issue. The objective of Strong Hearts, Healthy Communities (SHHC) is to reduce rural CVD disparities through civic engagement and implementation of a community-based intervention in 16 underserved rural towns. In Montana, SHHC builds upon a long-standing collaboration with National Institute of Food and Agriculture cooperative extension educators, who will implement the project. SHHC in New York will work with a health care system to implement the project. There is limited knowledge about how programs and services can move beyond commonly used individual-level approaches—which have limitations in terms of cost, impact, reach, and sustainability—to effectively reduce rural CVD health disparities using an integrated, multi-level, community-engaged approach. The objective of Strong Hearts, Healthy Communities (SHHC) is to address this gap in knowledge and practice by working with residents, practitioners, health educators, local leadership, and other stakeholders in 16 medically underserved rural towns to develop and test a comprehensive program designed to: a) improve diet and physical activity behaviors, b) promote local built environment resources, and c) shift social norms about active living and healthy eating through civic engagement, capacity building, and community-based programming.

FORMATIVE RESEARCH (STAGE1: Completed) The investigators conducted community audits, focus groups, and key informant interviews with members of the above key groups to gather in-depth data about a number of topics related to CVD awareness and risk factors. These topics included: economic, healthcare, and social/cultural factors, as well as, barriers and facilitators to healthy eating and active living. The community audit and qualitative data gathered during the formative research, as well as, feedback from extension educators and the National Advisory Board has informed and been incorporated in the development and refinement of the SHHC curriculum.

RANDOMIZED CONTROLLED INTERVENTION (STAGE 2) In the second phase of the project, the investigators will evaluate the efficacy of the SHHC curriculum in a 24-week community based randomized controlled intervention trial. The investigators will compare changes in CVD-related anthropometric, physiologic, behavioral, and psychosocial parameters between subjects in 8 intervention and 8 control communities. In addition, the investigators will evaluate changes in behavior, attitudes, and knowledge among SHHC intervention subjects' "social network".


Recruitment information / eligibility

Status Completed
Enrollment 194
Est. completion date February 15, 2020
Est. primary completion date June 2016
Accepts healthy volunteers No
Gender Female
Age group 40 Years and older
Eligibility Inclusion Criteria:

- Not currently physically active

- BMI greater than or equal to 25

- Blood pressure is less than 160/100 mm Hg

- Heart rate is between 60-100 bpm

- English-speaking

- Able and willing to obtain physician's approval to participate in either intervention

- Willing to participate in assessment activities

- Willing to make a firm commitment to participate in either intervention

Exclusion Criteria:

- Currently physically active

- Body Mass Index less than 25

- Untreated hypertension

- Heart rate lower than 60 or higher than 100 bpm

- Non-English speaking

- Not able or willing to obtain physician's approval to participate

- Not interested or willing to participate in assessment activities

- Not able or willing to make a firm commitment to participate in either intervention

Study Design


Intervention

Behavioral:
Strong Hearts, Healthy Communities
We will evaluate the efficacy of the SHHC curriculum in a 24-week community-based randomized controlled intervention trial. We will compare changes in CVD-related anthropometric, physiologic, behavioral, and psychosocial parameters between subjects in 8 intervention and 8 control communities. In addition, we will evaluate changes in behavior, attitudes, and knowledge among SHHC intervention subjects' "social network".
Strong Hearts, Healthy Women
The Strong Hearts, Healthy Women (minimal intervention) will meet once per month for an hour each time for 6 months. Participants will learn and discuss techniques and strategies to improve personal health.

Locations

Country Name City State
United States Broadus Broadus Montana
United States Cherry Valley Cherry Valley New York
United States Chinook Chinook Montana
United States Choteau Choteau Montana
United States Columbus Columbus Montana
United States Forsyth Forsyth Montana
United States Glasgow Glasgow Montana
United States Harlowton Harlowton Montana
United States Hinsdale Hinsdale Montana
United States Lewistown Lewistown Montana
United States Little Falls Little Falls New York
United States Plentywood Plentywood Montana
United States St. Johnsville Saint Johnsville New York
United States Shelby Shelby Montana
United States Sidney Sidney New York
United States Thompson Falls Thompson Falls Montana

Sponsors (4)

Lead Sponsor Collaborator
Cornell University Bassett Healthcare, Montana State University, Tufts University

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary Change in body weight Baseline to 6 months, 6-month follow-up, and 18-month follow-up
Secondary Changes in blood pressure Baseline to 6 months, 6-month follow-up, and 18-month follow-up
Secondary Changes in lipids Baseline to 6 months, 6-month follow-up, and 18-month follow-up
Secondary Changes in c-reactive protein Baseline to 6 months, 6-month follow-up, and 18-month follow-up
Secondary Changes in hemoglobin A1C Baseline to 6 months, 6-month follow-up, and 18-month follow-up
Secondary Changes in waist circumference Baseline to 3 months, 6 months, 6-month follow-up, and 18-month follow-up
Secondary Changes in 7-day accelerometry Baseline to 6 months, 6-month follow-up, and 18-month follow-up
Secondary Changes in 7-day dietary recall Baseline to 6 months, 6-month follow-up, and 18-month follow-up
Secondary Changes in healthy eating self-efficacy assessed by questionnaire Baseline to 3 months, 6 months, 6-month follow-up, one-year follow-up, and 18-month follow-up
Secondary Changes in exercise self-efficacy assessed by questionnaire Baseline to 3 months, 6 months, 6-month follow-up, one-year follow-up, and 18-month follow-up
Secondary Changes in healthy eating attitudes of social network of participants assessed by questionnaire Baseline to 6 months and 6-month follow-up
Secondary Changes in exercise attitudes of social network of participants assessed by questionnaire Baseline to 6 months and 6-month follow-up
Secondary Changes in healthy eating self-efficacy of social network of participants assessed by questionnaire Baseline to 6 months and 6-month follow-up
Secondary Changes in exercise self-efficacy of social network of participants assessed by questionnaire Baseline to 6 months and 6-month follow-up
See also
  Status Clinical Trial Phase
Recruiting NCT04243317 - Feasibility of a Sleep Improvement Intervention for Weight Loss and Its Maintenance in Sleep Impaired Obese Adults N/A
Recruiting NCT04101669 - EndoBarrier System Pivotal Trial(Rev E v2) N/A
Terminated NCT03772886 - Reducing Cesarean Delivery Rate in Obese Patients Using the Peanut Ball N/A
Completed NCT03640442 - Modified Ramped Position for Intubation of Obese Females. N/A
Completed NCT04506996 - Monday-Focused Tailored Rapid Interactive Mobile Messaging for Weight Management 2 N/A
Recruiting NCT06019832 - Analysis of Stem and Non-Stem Tibial Component N/A
Active, not recruiting NCT05891834 - Study of INV-202 in Patients With Obesity and Metabolic Syndrome Phase 2
Active, not recruiting NCT05275959 - Beijing (Peking)---Myopia and Obesity Comorbidity Intervention (BMOCI) N/A
Recruiting NCT04575194 - Study of the Cardiometabolic Effects of Obesity Pharmacotherapy Phase 4
Completed NCT04513769 - Nutritious Eating With Soul at Rare Variety Cafe N/A
Withdrawn NCT03042897 - Exercise and Diet Intervention in Promoting Weight Loss in Obese Patients With Stage I Endometrial Cancer N/A
Completed NCT03644524 - Heat Therapy and Cardiometabolic Health in Obese Women N/A
Recruiting NCT05917873 - Metabolic Effects of Four-week Lactate-ketone Ester Supplementation N/A
Active, not recruiting NCT04353258 - Research Intervention to Support Healthy Eating and Exercise N/A
Completed NCT04507867 - Effect of a NSS to Reduce Complications in Patients With Covid-19 and Comorbidities in Stage III N/A
Recruiting NCT03227575 - Effects of Brisk Walking and Regular Intensity Exercise Interventions on Glycemic Control N/A
Completed NCT01870947 - Assisted Exercise in Obese Endometrial Cancer Patients N/A
Recruiting NCT05972564 - The Effect of SGLT2 Inhibition on Adipose Inflammation and Endothelial Function Phase 1/Phase 2
Recruiting NCT06007404 - Understanding Metabolism and Inflammation Risks for Diabetes in Adolescents
Recruiting NCT05371496 - Cardiac and Metabolic Effects of Semaglutide in Heart Failure With Preserved Ejection Fraction Phase 2